Tenaya Other Operating Expenses from 2010 to 2024
| TNYA Stock | USD 2.04 0.11 5.12% |
Other Operating Expenses | First Reported 2010-12-31 | Previous Quarter 131.2 M | Current Value 87.2 M | Quarterly Volatility 37.1 M |
Check Tenaya Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenaya Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 7 M or Interest Income of 7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.8. Tenaya financial statements analysis is a perfect complement when working with Tenaya Therapeutics Valuation or Volatility modules.
Tenaya | Other Operating Expenses |
Latest Tenaya Therapeutics' Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Tenaya Therapeutics over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tenaya Therapeutics. It is also known as Tenaya Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Tenaya Therapeutics' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenaya Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Tenaya Other Operating Expenses Regression Statistics
| Arithmetic Mean | 48,855,045 | |
| Geometric Mean | 40,033,096 | |
| Coefficient Of Variation | 75.97 | |
| Mean Deviation | 29,516,466 | |
| Median | 27,712,000 | |
| Standard Deviation | 37,113,402 | |
| Sample Variance | 1377.4T | |
| Range | 103.5M | |
| R-Value | 0.75 | |
| Mean Square Error | 651T | |
| R-Squared | 0.56 | |
| Significance | 0 | |
| Slope | 6,216,567 | |
| Total Sum of Squares | 19283.7T |
Tenaya Other Operating Expenses History
About Tenaya Therapeutics Financial Statements
Tenaya Therapeutics stakeholders use historical fundamental indicators, such as Tenaya Therapeutics' Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Tenaya Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Tenaya Therapeutics' assets and liabilities are reflected in the revenues and expenses on Tenaya Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Tenaya Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 131.2 M | 87.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| F | Ford Motor | |
| CRM | Salesforce |
Check out the analysis of Tenaya Therapeutics Correlation against competitors. For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenaya Therapeutics. If investors know Tenaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenaya Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Return On Assets (0.41) | Return On Equity (0.75) |
The market value of Tenaya Therapeutics is measured differently than its book value, which is the value of Tenaya that is recorded on the company's balance sheet. Investors also form their own opinion of Tenaya Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenaya Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenaya Therapeutics' market value can be influenced by many factors that don't directly affect Tenaya Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenaya Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenaya Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenaya Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.